Renal thrombotic microangiopathy associated with chronic humoral graft versus host disease after hematopoietic stem cell transplantation

Pathology International

Volumn 61, Issue 1, 2011, Pages 34-41

  Mii, Akiko ^a   Shimizu, Akira ^a   Masuda, Yukinari ^a   Fujino, Teppei ^a   Kaneko, Tomohiro ^a   Utsumi, Kouichi ^a   Arai, Takashi ^a   Ishikawa, Arimi ^a   Wakamatsu, Kyoko ^a   Tajika, Kenji ^a   Iino, Yasuhiko ^a   Katayama, Yasuo ^a   Fukuda, Yuh ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Antibody; C4d; Chronic GVHD; Hematopoietic stem cell transplantation; Kidney; Thrombotic microangiopathy

Indexed keywords

ANTIBODY; COMPLEMENT COMPONENT C4D; CREATININE; CYCLOPHOSPHAMIDE; FLUDARABINE; TACROLIMUS;

ADULT; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; ENDOTHELIUM CELL; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; KIDNEY TUBULE DISORDER; MALE; MICROTHROMBUS; PRIORITY JOURNAL; PROTEINURIA; THROMBOTIC THROMBOCYTOPENIC PURPURA; WHOLE BODY RADIATION;

COMPLEMENT C4B; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; THROMBOTIC MICROANGIOPATHIES;

EID: 78650230608     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2010.02608.x     Document Type: Article

References (37)

1. Parikh CR, Coca SG. Acute renal failure in hematopoietic cell transplantation. Kidney Int 2006; 69: 430-35.
2. Hingorani S. Chronic kidney disease in long-term survivors of hematopoietic cell transplantation: Epidemiology, pathogenesis, and treatment. J Am Soc Nephrol 2006; 17: 1995-2005.
3. Hingorani S, Guthrie KA, Schoch G, Weiss NS, McDonald GB. Chronic kidney disease in long-term survivors of hematopoietic cell transplant. Bone Marrow Transplant 2007; 39: 223-9.
4. Chang A, Hingorani S, Kowalewska J et al. Spectrum of renal pathology in hematopoietic cell transplantation: A series of 20 patients and review of the literature. Clin J Am Soc Nephrol 2007; 2: 1014-23.
5. Troxell ML, Pilapil M, Miklos DB, Higgins JP, Kambham N. Renal pathology in hematopoietic cell transplantation recipients. Mod Pathol 2008; 21: 396-406.
6. Chan GS, Lam MF, Au WY et al. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation. Nephrology (Carlton) 2008; 13: 322-30.
7. Iskandar SS, Browning MC, Lorentz WB. Mesangiolytic glomerulopathy in a bone marrow allograft recipient. Hum Pathol 1989; 20: 290-92.
8. Changsirikulchai S, Myerson D, Guthrie KA, McDonald GB, Alpers CE, Hingorani SR. Renal thrombotic microangiopathy after hematopoietic cell transplant: Role of GVHD in pathogenesis. Clin J Am Soc Nephrol 2009; 4: 345-53.
9. Pettitt AR, Clark RE. Thrombotic microangiopathy following bone marrow transplantation. Bone Marrow Transplant 1994; 14: 495-504.
10. Busca A, Uderzo C. BMT: Bone marrow transplant associated thrombotic microangiopathy. Hematology 2000; 5: 53-67.
11. Iacopino P, Pucci G, Arcese W et al. Severe thrombotic microangiopathy: An infrequent complication of bone marrow transplantation. Gruppo Italiano Trapianto Midollo Osseo (GITMO). Bone Marrow Transplant 1999; 24: 47-51.
12. Siami K, Kojouri K, Swisher KK, Selby GB, George JN, Laszik ZG. Thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation: An autopsy study. Transplantation 2008; 85: 22-8.
13. Otani M, Shimojo H, Shiozawa S, Shigematsu H. Renal involvement in bone marrow transplantation. Nephrology (Carlton) 2005; 10: 530-36.
14. Uderzo C, Bonanomi S, Busca A et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 2006; 82: 638-44.
15. Kusumi E, Kami M, Hara S et al. Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: Possible involvement of graft-versus-host disease. Int J Hematol 2008; 87: 225-30.
16. The Japan Society for Hematopoietic Stem Cell Transplantation JHSCT guideline graft-versus-host disease (GVHD) [homepage on the Internet]. (cited October 6 2010) Available from:
17. Colvin RB. Antibody-mediated renal allograft rejection: Diagnosis and pathogenesis. J Am Soc Nephrol 2007; 18: 1046-56.
18. Marshall RJ, Sweny P. Haemolytic-uraemic syndrome in recipients of bone marrow transplants not treated with cyclosporin A. Histopathology 1986; 10: 953-62.
19. Elliott MA, Nichols WL Jr, Plumhoff EA et al. Posttransplantation thrombotic thrombocytopenic purpura: A single-center experience and a contemporary review. Mayo Clin Proc 2003; 78: 421-30.
20. Nickeleit V, Mihatsch MJ. Kidney transplants, antibodies and rejection: Is C4d a magic marker? Nephrol Dial Transplant 2003; 18: 2232-9.
21. Solez K, Colvin RB, Racusen LC et al. Banff 07 classification of renal allograft pathology: Updates and future directions. Am J Transplant 2008; 8: 753-60.
22. Sis B, Mengel M, Haas M et al. Banff '09 meeting report: Antibody mediated graft deterioration and implementation of banff working groups. Am J Transplant 2010.
23. Platt JL. C4d and the fate of organ allografts. J Am Soc Nephrol 2002; 13: 2417-19.
24. Regele H, Bohmig GA, Habicht A et al. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: A contribution of humoral immunity to chronic allograft rejection. J Am Soc Nephrol 2002; 13: 2371-80.
25. Solez K, Colvin RB, Racusen LC et al. Banff '05 meeting report: Differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN'). Am J Transplant 2007; 7: 518-26.
26. Kayler LK, Kiss L, Sharma V et al. Acute renal allograft rejection: Diagnostic significance of focal peritubular capillary C4d. Transplantation 2008; 85: 813-20.
27. Kedainis RL, Koch MJ, Brennan DC, Liapis H. Focal C4d+ in renal allografts is associated with the presence of donor-specific antibodies and decreased allograft survival. Am J Transplant 2009; 9: 812-19.
28. Einecke G, Sis B, Reeve J et al. Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure. Am J Transplant 2009; 9: 2520-31.
29. Sijpkens YW, Joosten SA, Wong MC et al. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy. Kidney Int 2004; 65: 2409-18.
30. Yamamoto I, Horita S, Takahashi T et al. Glomerular expression of plasmalemmal vesicle-associated protein-1 in patients with transplant glomerulopathy. Am J Transplant 2007; 7: 1954-60.
31. Terrier B, Delmas Y, Hummel A et al. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: Clinical presentation, outcome and pathogenic aspects. Nephrol Dial Transplant 2007; 22: 1369-76.
32. Reddy P, Johnson K, Uberti JP et al. Nephrotic syndrome associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2006; 38: 351-7.
33. Shimabukuro-Vornhagen A, Hallek MJ, Storb RF, von Bergwelt-Baildon MS. The role of B cells in the pathogenesis of graft-versus-host disease. Blood 2009; 114: 4919-27.
34. Kapur R, Ebeling S, Hagenbeek A. B-cell involvement in chronic graft-versus-host disease. Haematologica 2008; 93: 1702-11.
35. Alousi AM, Uberti J, Ratanatharathorn V. The role of B cell depleting therapy in graft versus host disease after allogeneic hematopoietic cell transplant. Leuk Lymphoma 2010; 51: 376-89.
36. Cutler C, Miklos D, Kim HT et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006; 108: 756-62.
37. Au WY, Ma ES, Lee TL et al. Successful treatment of thrombotic microangiopathy after haematopoietic stem cell transplantation with rituximab. Br J Haematol 2007; 137: 475-8.